NO771828L - 3,5,5-trimetylheksanoyl-ferrocen og fremgangsm}te til dets fremstilling - Google Patents
3,5,5-trimetylheksanoyl-ferrocen og fremgangsm}te til dets fremstillingInfo
- Publication number
- NO771828L NO771828L NO771828A NO771828A NO771828L NO 771828 L NO771828 L NO 771828L NO 771828 A NO771828 A NO 771828A NO 771828 A NO771828 A NO 771828A NO 771828 L NO771828 L NO 771828L
- Authority
- NO
- Norway
- Prior art keywords
- ferrocene
- water
- trimethylhexanoyl
- isononanoic acid
- chloride
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 14
- -1 3,5,5-TRIMETHYLHEXANOYL-FERROCEN Chemical compound 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 35
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 18
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 claims description 15
- ACNAXEZQQXXWAE-UHFFFAOYSA-M cyclopenta-1,3-diene;1-cyclopenta-2,4-dien-1-ylidene-3,5,5-trimethylhexan-1-olate;iron(2+) Chemical compound [Fe+2].C=1C=C[CH-]C=1.CC(C)(C)CC(C)CC([O-])=C1C=CC=C1 ACNAXEZQQXXWAE-UHFFFAOYSA-M 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- GEKPNPPFAYJZRD-UHFFFAOYSA-N 3,5,5-trimethylhexanoyl chloride Chemical compound ClC(=O)CC(C)CC(C)(C)C GEKPNPPFAYJZRD-UHFFFAOYSA-N 0.000 claims description 4
- 239000012442 inert solvent Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- NIZXKFMBIKTSPI-UHFFFAOYSA-N 7-methyloctanoyl 7-methyloctanoate Chemical compound CC(C)CCCCCC(=O)OC(=O)CCCCCC(C)C NIZXKFMBIKTSPI-UHFFFAOYSA-N 0.000 claims description 3
- 238000005727 Friedel-Crafts reaction Methods 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 3
- 239000012074 organic phase Substances 0.000 claims 3
- 239000005457 ice water Substances 0.000 claims 2
- 239000000047 product Substances 0.000 claims 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 2
- 239000013078 crystal Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 239000000155 melt Substances 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 235000021395 porridge Nutrition 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 238000001665 trituration Methods 0.000 claims 1
- 230000007306 turnover Effects 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 33
- 229910052742 iron Inorganic materials 0.000 description 16
- 102000008857 Ferritin Human genes 0.000 description 12
- 108050000784 Ferritin Proteins 0.000 description 12
- 238000008416 Ferritin Methods 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 239000000126 substance Substances 0.000 description 5
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 108010017480 Hemosiderin Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010022971 Iron Deficiencies Diseases 0.000 description 2
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- ASMGEGYMKGCJAI-UHFFFAOYSA-N 5-(2,2-dimethylpropyl)cyclopenta-1,3-diene;iron(2+) Chemical compound [Fe+2].CC(C)(C)CC1=CC=C[CH-]1.CC(C)(C)CC1=CC=C[CH-]1 ASMGEGYMKGCJAI-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102000000546 Apoferritins Human genes 0.000 description 1
- 108010002084 Apoferritins Proteins 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- FTGPQMNJQQHSBO-UHFFFAOYSA-N C(C1CCCCC1)(=O)[C-]1C=CC=C1.[CH-]1C=CC=C1.[Fe+2] Chemical compound C(C1CCCCC1)(=O)[C-]1C=CC=C1.[CH-]1C=CC=C1.[Fe+2] FTGPQMNJQQHSBO-UHFFFAOYSA-N 0.000 description 1
- BUELAXYCKGTDOC-UHFFFAOYSA-N C1(CCCCC1)C(=O)[C-]1C=CC=C1.[C-]1(C=CC=C1)C(=O)C1CCCCC1.[Fe+2] Chemical compound C1(CCCCC1)C(=O)[C-]1C=CC=C1.[C-]1(C=CC=C1)C(=O)C1CCCCC1.[Fe+2] BUELAXYCKGTDOC-UHFFFAOYSA-N 0.000 description 1
- MPDDVPKGVKVHEY-UHFFFAOYSA-N CC(CC(=O)[C-]1C=CC=C1)CC(C)(C)C.[C-]1(C=CC=C1)C(CC(CC(C)(C)C)C)=O.[Fe+2] Chemical compound CC(CC(=O)[C-]1C=CC=C1)CC(C)(C)C.[C-]1(C=CC=C1)C(CC(CC(C)(C)C)C)=O.[Fe+2] MPDDVPKGVKVHEY-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010065973 Iron Overload Diseases 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- RTEPBHXQWIXRTK-UHFFFAOYSA-N [C].[S].[S] Chemical compound [C].[S].[S] RTEPBHXQWIXRTK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
- C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Compounds Of Iron (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2623486A DE2623486C2 (de) | 1976-05-26 | 1976-05-26 | 3.5.5-Trimethylhexanoyl-ferrocen, Verfahren zu seiner Herstellung und pharmazeutische Präparate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO771828L true NO771828L (no) | 1977-11-29 |
Family
ID=5978988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO771828A NO771828L (no) | 1976-05-26 | 1977-05-25 | 3,5,5-trimetylheksanoyl-ferrocen og fremgangsm}te til dets fremstilling |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4118509A (fi) |
| JP (1) | JPS535144A (fi) |
| AT (1) | AT350071B (fi) |
| AU (1) | AU515495B2 (fi) |
| BE (1) | BE855092A (fi) |
| CA (1) | CA1089481A (fi) |
| CH (1) | CH629818A5 (fi) |
| DE (1) | DE2623486C2 (fi) |
| DK (1) | DK228677A (fi) |
| EG (1) | EG12752A (fi) |
| ES (1) | ES458991A1 (fi) |
| FI (1) | FI62315C (fi) |
| FR (1) | FR2352825A1 (fi) |
| GB (1) | GB1537974A (fi) |
| GR (1) | GR72094B (fi) |
| HU (1) | HU175611B (fi) |
| IE (1) | IE44763B1 (fi) |
| IL (1) | IL52152A (fi) |
| IT (1) | IT1078980B (fi) |
| NL (1) | NL7705582A (fi) |
| NO (1) | NO771828L (fi) |
| NZ (1) | NZ184185A (fi) |
| PH (1) | PH13503A (fi) |
| PT (1) | PT66599B (fi) |
| SE (1) | SE426947B (fi) |
| ZA (1) | ZA773160B (fi) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2815930A1 (de) * | 1978-04-13 | 1979-10-18 | Bayer Ag | Duengemittel zur versorgung von pflanzen mit eisen |
| DE3404443A1 (de) * | 1984-02-08 | 1985-08-08 | Hartmut Prof. Dr. 1000 Berlin Köpf | Metallicenium-salze und deren verwendung als cytostatica bei der krebsbekaempfung |
| EP0336538A1 (en) * | 1988-02-24 | 1989-10-11 | The British Petroleum Company p.l.c. | Process for preparing chiral sulphoxides |
| FR2667600B1 (fr) * | 1990-10-03 | 1993-07-23 | Poudres & Explosifs Ste Nale | Procede de synthese de monohalogenoalcanoylferrocenes. |
| US5863911A (en) * | 1994-10-12 | 1999-01-26 | Modelisation Et Mise Au Point De Molecules Medicinales | Diarylethylene metallocene derivatives, their processes of preparation and pharmaceutical compositions containing said derivatives |
| FR2725720B1 (fr) * | 1994-10-12 | 1997-01-03 | Modelisation Et Mise Au Point | Derives metalloceniques du diarylethylene, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits derives |
| PT1072198E (pt) * | 1999-07-28 | 2008-06-17 | Swiss Caps Rechte & Lizenzen | Preparado, especialmente para utilização como medicamento e/ou como suplemento alimentar |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE570298A (fi) * | 1957-08-12 | |||
| GB898633A (en) * | 1957-08-12 | 1962-06-14 | Ici Ltd | Ferrocene derivatives |
| GB861834A (en) * | 1959-01-07 | 1961-03-01 | Ici Ltd | Ferrocene derivatives |
| GB864197A (en) * | 1959-01-07 | 1961-03-29 | Ici Ltd | An improved process for the manufacture of monopivalylferrocene derivatives |
| BE587379A (fi) * | 1959-02-09 | |||
| US3432533A (en) * | 1966-10-28 | 1969-03-11 | Us Air Force | Perfluoroalkyl and perfluoroacyl ferrocenes |
| US3960911A (en) * | 1973-11-21 | 1976-06-01 | Frisons Limited | Ferrocene compounds and preparation |
| US3966783A (en) * | 1973-11-21 | 1976-06-29 | Fisons Limited | Compounds |
| IL48713A0 (en) * | 1975-01-15 | 1976-02-29 | Fisons Ltd | Novel ferrocene derivatives,their production and pharmaceutical compositions containing them |
-
1976
- 1976-05-26 DE DE2623486A patent/DE2623486C2/de not_active Expired
-
1977
- 1977-05-20 NL NL7705582A patent/NL7705582A/xx not_active Application Discontinuation
- 1977-05-20 ES ES458991A patent/ES458991A1/es not_active Expired
- 1977-05-23 CH CH635177A patent/CH629818A5/de not_active IP Right Cessation
- 1977-05-24 SE SE7706061A patent/SE426947B/xx not_active Application Discontinuation
- 1977-05-24 EG EG316/77A patent/EG12752A/xx active
- 1977-05-24 IT IT23959/77A patent/IT1078980B/it active
- 1977-05-24 US US05/799,973 patent/US4118509A/en not_active Expired - Lifetime
- 1977-05-24 GB GB21809/77A patent/GB1537974A/en not_active Expired
- 1977-05-24 PH PH19809A patent/PH13503A/en unknown
- 1977-05-24 IL IL52152A patent/IL52152A/xx unknown
- 1977-05-24 FI FI771641A patent/FI62315C/fi not_active IP Right Cessation
- 1977-05-24 GR GR53550A patent/GR72094B/el unknown
- 1977-05-24 NZ NZ184185A patent/NZ184185A/xx unknown
- 1977-05-25 DK DK228677A patent/DK228677A/da not_active Application Discontinuation
- 1977-05-25 ZA ZA00773160A patent/ZA773160B/xx unknown
- 1977-05-25 IE IE1076/77A patent/IE44763B1/en unknown
- 1977-05-25 NO NO771828A patent/NO771828L/no unknown
- 1977-05-25 PT PT66599A patent/PT66599B/pt unknown
- 1977-05-25 AT AT373477A patent/AT350071B/de not_active IP Right Cessation
- 1977-05-25 CA CA279,097A patent/CA1089481A/en not_active Expired
- 1977-05-25 HU HU77HO1990A patent/HU175611B/hu unknown
- 1977-05-25 AU AU25465/77A patent/AU515495B2/en not_active Expired
- 1977-05-26 FR FR7716135A patent/FR2352825A1/fr active Granted
- 1977-05-26 BE BE177954A patent/BE855092A/xx not_active IP Right Cessation
- 1977-05-26 JP JP6055277A patent/JPS535144A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL52152A0 (en) | 1977-07-31 |
| ES458991A1 (es) | 1978-02-16 |
| IT1078980B (it) | 1985-05-08 |
| US4118509A (en) | 1978-10-03 |
| AU2546577A (en) | 1978-11-30 |
| NZ184185A (en) | 1979-04-26 |
| ZA773160B (en) | 1978-04-26 |
| DE2623486A1 (de) | 1977-12-15 |
| FR2352825A1 (fr) | 1977-12-23 |
| AU515495B2 (en) | 1981-04-09 |
| EG12752A (en) | 1980-03-31 |
| DK228677A (da) | 1977-11-27 |
| PT66599B (de) | 1979-01-22 |
| BE855092A (fr) | 1977-11-28 |
| CA1089481A (en) | 1980-11-11 |
| JPS535144A (en) | 1978-01-18 |
| SE426947B (sv) | 1983-02-21 |
| PT66599A (de) | 1977-06-01 |
| IL52152A (en) | 1980-12-31 |
| DE2623486C2 (de) | 1982-12-30 |
| AT350071B (de) | 1979-05-10 |
| PH13503A (en) | 1980-05-28 |
| FR2352825B1 (fi) | 1980-07-04 |
| FI62315C (fi) | 1982-12-10 |
| HU175611B (hu) | 1980-09-28 |
| IE44763L (en) | 1977-11-26 |
| SE7706061L (sv) | 1977-11-27 |
| FI771641A (fi) | 1977-11-27 |
| FI62315B (fi) | 1982-08-31 |
| NL7705582A (nl) | 1977-11-29 |
| GB1537974A (en) | 1979-01-10 |
| IE44763B1 (en) | 1982-03-24 |
| ATA373477A (de) | 1978-10-15 |
| GR72094B (fi) | 1983-09-13 |
| CH629818A5 (de) | 1982-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI74705C (fi) | Foerfarande foer framstaellning av nya kristallina bensotiazindioxidsalter. | |
| NO771828L (no) | 3,5,5-trimetylheksanoyl-ferrocen og fremgangsm}te til dets fremstilling | |
| US3676554A (en) | Anti-arthritic compositions comprising phosphine or phosphite gold halide complexes and methods of producing anti-arthritic activity | |
| US4939164A (en) | Strontium salt | |
| GB2098215A (en) | Thiazolidine derivatives and their preparation and pharmaceutical formulation | |
| US4036983A (en) | Ferrocene compounds and pharmaceutical composition for use in treatment of iron deficiency in an animal | |
| US3870792A (en) | Certain dihydrophthalizines for treating hemorrhage and thrombosis | |
| US4141991A (en) | Ferrocene derivatives | |
| US4094988A (en) | Method of treating gastric ulcers using 5,6-dihydro-1,4-dithiinoxides | |
| EP0003897B1 (en) | Phosphinegold(i)salts, process for their preparation and compositions containing them | |
| US4287355A (en) | Carboxyl-(phenyl or tolyl)-sulfonium salts | |
| KR810000910B1 (ko) | 페로센 유도체의 제조방법 | |
| US4233292A (en) | Cyclopropyl sulfonium salts | |
| JPS6119632B2 (fi) | ||
| US4057630A (en) | Antiarthritic compositions comprising bis-coordinated gold(1+) salts and methods of producing antiarthritic activity | |
| US4093719A (en) | Antiarthritic compositions comprising bis[(trialkyl-phosphine)gold(I)]sulfides and methods of producing antiarthritic activity | |
| US4740506A (en) | Bis(trimethaphan)-nitroprusside salts and use thereof for blood pressure reduction | |
| US4098887A (en) | Pharmaceutical compositions and methods of producing antiarthritic activity with bis(pyridine)gold(1+) salts | |
| US3941888A (en) | Substituted or unsubstituted p-alkanoyl toluenes as hypolipidemics | |
| US3560617A (en) | Pharmaceutical composition containing 3-butylamino - 4 - chloro-5-sulphamylbenzoic acids and salts thereof for the treatment of oedematous conditions and hypertension | |
| DE1904585C3 (de) | Ester der 7-(a-Amino-a- phenylacetamido)cephalosporansaure und ihre Herstellung | |
| US3644395A (en) | Phenylbutazone-sodium-monoglycerate | |
| US3733418A (en) | Method of treating hyperlipemia using bis(substituted phenyl) acetals | |
| KR810000911B1 (ko) | "3,5,5-트리메칠 헥사노일 페로센"의 제조방법 | |
| AT330745B (de) | Verfahren zur herstellung von neuen 4- aminophenoxy- oder 4- aminophenylthio- 3-amino-5-sulfamoyl-benzoesauren sowie deren niederalkylestern und salzen |